From: Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT
Site of involvement | FDG-positive lesions | FDG-negative lesions | Both FDG-positive and FDG-negative lesions | Total |
---|---|---|---|---|
n (%) | n (%) | n (%) | n(%) | |
Lung | 4 (7.14%) | 14 (25%) | 13 (23.21%) | 31/56 (55.3%) |
Skeletal | 17 (30.36%) | 1 (1.79%) | 0 | 18/56(32.1%) |
Peritoneum | 0 | 2 (3.57%) | 0 | 2/56(3.5%) |
Brain | 1 (1.79%) | 0 | 0 | 1/56(1.79%) |
Spleen | 1 (1.79%) | 0 | 0 | 1/56 (1.79%) |
Adrenal gland | 5 (8.93%) | 2 (3.57%) | 0 | 7/56(12.5%) |
Muscle | 1 (1.79%) | 0 | 0 | 1/56 (1.79%) |
Lymphnodal metastases | ||||
Regional lymph nodes | 15 (26.79%) | 5 (8.93%) | 5 (8.93%) | 25/56 (44.65%) |
Distant lymph nodes | 14 (25%) | 5 (8.93%) | 3 (5.36%) | 22/56 (39.2%) |